financetom
Business
financetom
/
Business
/
S&P Global Insider Sold Shares Worth $998,526, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&P Global Insider Sold Shares Worth $998,526, According to a Recent SEC Filing
Aug 8, 2025 1:26 PM

04:11 PM EDT, 08/08/2025 (MT Newswires) -- Edouard Tavernier, President, S&P Global Mobility, on August 06, 2025, sold 1,799 shares in S&P Global ( SPGI ) for $998,526. Following the Form 4 filing with the SEC, Tavernier has control over a total of 17,138 common shares of the company, with 17,138 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/64040/000006404025000153/xslF345X05/wk-form4_1754683255.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck secures $700 million funding from Blackstone to develop cancer therapy
Merck secures $700 million funding from Blackstone to develop cancer therapy
Nov 4, 2025
Nov 4 (Reuters) - Merck ( MRK ) said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy. Under the terms of the agreement, Blackstone will fund a portion of the development costs to test sac-TMT, an experimental antibody-drug conjugate. Antibody-drug conjugates are...
Harley-Davidson Q3 Earnings, Revenue Rise
Harley-Davidson Q3 Earnings, Revenue Rise
Nov 4, 2025
07:08 AM EST, 11/04/2025 (MT Newswires) -- Harley-Davidson ( HOG ) reported Q3 earnings Tuesday of $3.10 per diluted share, up from $0.91 a year earlier. Analysts polled by FactSet expected $1.53. Revenue for the quarter ended Sept. 30 was $1.34 billion, compared with $1.15 billion a year earlier. Analysts surveyed by FactSet expected $1.01 billion. The company said it...
BRIEF-LakeShore Biopharma Enters Into Definitive Agreement For Going-Private Transaction
BRIEF-LakeShore Biopharma Enters Into Definitive Agreement For Going-Private Transaction
Nov 4, 2025
Nov 4 (Reuters) - LakeShore Biopharma Co Ltd ( LSBWF ): * LAKESHORE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT FOR GOING-PRIVATE TRANSACTION * LAKESHORE BIOPHARMA CO LTD ( LSBWF ) - ENTERS AGREEMENT FOR MERGER WITH OCEANPINE SKYLINE INC * LAKESHORE BIOPHARMA CO LTD ( LSBWF ) - CO SHAREHOLDERS TO RECEIVE $0.90 PER SHARE IN CASH * LAKESHORE BIOPHARMA CO...
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales
Nov 4, 2025
Overview * Rhythm Q3 2025 product revenue rises 54% yr/yr, driven by IMCIVREE sales * Net income for Q3 2025 misses analyst expectations, larger loss reported * FDA accepts sNDA for setmelanotide in acquired hypothalamic obesity, decision by Dec 20 Outlook * Company expects FDA decision on sNDA by December 20, 2025 * Rhythm anticipates Q4 2025 results from Phase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved